Zacks Company Profile for The Cooper Companies, Inc. (COO : NSDQ) |
|
|
|
Company Description |
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
Number of Employees: 16,000 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $73.02 |
Daily Weekly Monthly
 |
20 Day Moving Average: 2,918,938 shares |
Shares Outstanding: 199.98 (millions) |
Market Capitalization: $14,602.63 (millions) |
Beta: 0.99 |
52 Week High: $112.38 |
52 Week Low: $65.00 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
8.31% |
3.84% |
12 Week |
-6.26% |
-17.86% |
Year To Date |
-20.57% |
-24.98% |
|
|
|
|
|
Address & Contact Information |
Street Address |
Phone / Fax |
Email Address |
Web URL |
6101 Bollinger Canyon Road Suite 500 - San Ramon,CA 94583 USA |
ph: 925-460-3600 fax: 925-460-3649 |
ir@cooperco.com |
http://www.coopercos.com |
|
|
|
General Corporate Information |
Officers
Albert G. White, III - President; Chief Executive Officer and Director
Robert S. Weiss - Chairman
William A. Kozy - Vice Chairman
Brian G. Andrews - Executive Vice President; Chief Financial Officer
Agostino Ricupati - Senior Vice President and Chief Accounting Officer
|
|
Peer Information
The Cooper Companies, Inc. (ITRJ)
The Cooper Companies, Inc. (BRLI.)
The Cooper Companies, Inc. (GOGY)
The Cooper Companies, Inc. (PSTX.)
The Cooper Companies, Inc. (ELGXQ)
The Cooper Companies, Inc. (CAH)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED/DENTAL-SUPP
Sector: Medical
CUSIP: 216648501
SIC: 3851
|
|
Fiscal Year
Fiscal Year End: October
Last Reported Quarter: 04/01/25
Next Expected EPS Date: 08/27/25
|
|
Share - Related Items
Shares Outstanding: 199.98
Most Recent Split Date: 2.00 (4.00:1)
Beta: 0.99
Market Capitalization: $14,602.63 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $1.06 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $4.06 |
Payout Ratio: 0.00 |
Number of Estimates in the Fiscal Year Consensus: 8.00 |
Change In Payout Ratio: 0.00 |
Estmated Long-Term EPS Growth Rate: 10.10% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/27/25 |
|
|
|
|